These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 23186380)

  • 1. Drug salt formation via mechanochemistry: the case study of vincamine.
    Hasa D; Perissutti B; Cepek C; Bhardwaj S; Carlino E; Grassi M; Invernizzi S; Voinovich D
    Mol Pharm; 2013 Jan; 10(1):211-24. PubMed ID: 23186380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced oral bioavailability of vinpocetine through mechanochemical salt formation: physico-chemical characterization and in vivo studies.
    Hasa D; Voinovich D; Perissutti B; Grassi M; Bonifacio A; Sergo V; Cepek C; Chierotti MR; Gobetto R; Dall'Acqua S; Invernizzi S
    Pharm Res; 2011 Aug; 28(8):1870-83. PubMed ID: 21424156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanochemical activation of vincamine mediated by linear polymers: assessment of some "critical" steps.
    Hasa D; Perissutti B; Grassi M; Chierotti MR; Gobetto R; Ferrario V; Lenaz D; Voinovich D
    Eur J Pharm Sci; 2013 Sep; 50(1):56-68. PubMed ID: 23524254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale of using Vinca minor Linne dry extract phytocomplex as a vincamine's oral bioavailability enhancer.
    Hasa D; Perissutti B; Dall'Acqua S; Chierotti MR; Gobetto R; Grabnar I; Cepek C; Voinovich D
    Eur J Pharm Biopharm; 2013 May; 84(1):138-44. PubMed ID: 23238273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanochemically induced disordered structures of vincamine: the different mediation of two cross-linked polymers.
    Hasa D; Perissutti B; Chierotti MR; Gobetto R; Grabnar I; Bonifacio A; Dall'Acqua S; Invernizzi S; Voinovich D
    Int J Pharm; 2012 Oct; 436(1-2):41-57. PubMed ID: 22721852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Situ Salification in Polar Solvents: a Paradigm for Enabling Drug Delivery of Weakly Ionic Drugs as Amorphous Solid Dispersion.
    Nair R; Lamare I; Tiwari NK; Ravi PR; Pillai R
    AAPS PharmSciTech; 2018 Jan; 19(1):326-337. PubMed ID: 28721630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.
    Skrdla PJ; Zhang D
    J Pharm Biomed Anal; 2014 Mar; 90():186-91. PubMed ID: 24378612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel dry powder inhaler formulation of glucagon with addition of citric acid for enhanced pulmonary delivery.
    Onoue S; Yamamoto K; Kawabata Y; Hirose M; Mizumoto T; Yamada S
    Int J Pharm; 2009 Dec; 382(1-2):144-50. PubMed ID: 19703531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability.
    Wang J; Chang R; Zhao Y; Zhang J; Zhang T; Fu Q; Chang C; Zeng A
    AAPS PharmSciTech; 2017 Oct; 18(7):2541-2550. PubMed ID: 28224393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
    Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
    Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in solubility and bioavailability of puerarin by mechanochemical preparation.
    Xie J; Yang F; Shi X; Zhu X; Su W; Wang P
    Drug Dev Ind Pharm; 2013 Jun; 39(6):826-35. PubMed ID: 22591175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.
    Pokharkar V; Khanna A; Venkatpurwar V; Dhar S; Mandpe L
    Acta Pharm; 2009 Jun; 59(2):121-32. PubMed ID: 19564138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary approach on characterizing a mechanochemically activated composite of vinpocetine and crospovidone.
    Hasa D; Voinovich D; Perissutti B; Bonifacio A; Grassi M; Franceschinis E; Dall'Acqua S; Speh M; Plavec J; Invernizzi S
    J Pharm Sci; 2011 Mar; 100(3):915-32. PubMed ID: 20839363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation of poorly water-soluble drugs into organic nanotubes for improving drug dissolution.
    Moribe K; Makishima T; Higashi K; Liu N; Limwikrant W; Ding W; Masuda M; Shimizu T; Yamamoto K
    Int J Pharm; 2014 Jul; 469(1):190-6. PubMed ID: 24746412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a rational vs. high throughput approach for rapid salt screening and selection.
    Collman BM; Miller JM; Seadeek C; Stambek JA; Blackburn AC
    Drug Dev Ind Pharm; 2013 Jan; 39(1):29-38. PubMed ID: 22380522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of drug supersaturation for rational early formulation screening of surfactant/co-solvent drug delivery systems.
    Stillhart C; Cavegn M; Kuentz M
    J Pharm Pharmacol; 2013 Feb; 65(2):181-92. PubMed ID: 23278685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs.
    Nkansah P; Antipas A; Lu Y; Varma M; Rotter C; Rago B; El-Kattan A; Taylor G; Rubio M; Litchfield J
    J Control Release; 2013 Jul; 169(1-2):150-61. PubMed ID: 23570985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.